| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Dermatology University of Michigan Medical School Ann Arbor, Michigan 48109
1,25-Dihydroxyvitamin D3 (D3) exerts its effects by binding to and activating nuclear vitamin D3 receptors (VDRs) that regulate transcription of target genes. We have investigated regulation of VDR levels in human skin in vivo and in cultured human keratinocytes. Quantitative ligand-binding analysis revealed that human skin expressed approximately 220 VDRs per cell, which bound D3 with high affinity [(dissociation constant (Kd) = 0.22 nM]. In human skin nuclear extracts, VDR exclusively bound to DNA containing vitamin D3 response elements as heterodimers with retinoid X receptors. Topical application of D3 to human skin elevated VDR protein levels 2-fold, as measured by both ligand-binding and DNA-binding assays. In contrast, the D3 analog calcipotriene had no effect on VDR levels. Topical D3 had no effect on VDR mRNA, indicating that D3 either stimulated synthesis and/or inhibited degradation of VDRs. To investigate this latter possibility, recombinant VDRs were incubated with skin lysates in the presence or absence of D3. The presence of D3 substantially protected VDRs against degradation by human skin lysates. VDR degradation was inhibited by proteasome inhibitors, but not lysosome or serine protease inhibitors. In cultured keratinocytes, D3 or proteasome inhibitors increased VDR protein without affecting VDR mRNA levels. In cells, VDR was ubiquitinated and this ubiquitination was inhibited by D3. Proteasome inhibitors in combination with D3 enhanced VDR-mediated gene expression, as measured by induction of vitamin D3 24-hydroxylase mRNA in cultured keratinocytes. Taken together, our findings indicate that low VDR levels are maintained, in part, through ubiquitin/proteasome-mediated degradation and that low VDR levels limit D3 signaling. D3 exerts dual positive influences on its nuclear receptor, simultaneously stimulating VDR transactivation activity and retarding VDR degradation.
This article has been cited by other articles:
![]() |
P. J. Malloy, J. Wang, K. Jensen, and D. Feldman Modulation of Vitamin D Receptor Activity by the Corepressor Hairless: Differential Effects of Hairless Isoforms Endocrinology, November 1, 2009; 150(11): 4950 - 4957. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Kim, J. M. Yoon, A H. Choi, W. S. Kim, G. Y. Lee, and J. B. Kim Liver X Receptor Ligands Suppress Ubiquitination and Degradation of LXR{alpha} by Displacing BARD1/BRCA1 Mol. Endocrinol., April 1, 2009; 23(4): 466 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Deng, E. Ueda, K. E. Chen, C. Bula, A. W. Norman, R. A. Luben, and A. M. Walker Prolactin Blocks Nuclear Translocation of VDR by Regulating Its Interaction with BRCA1 in Osteosarcoma Cells Mol. Endocrinol., February 1, 2009; 23(2): 226 - 236. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Malloy and D. Feldman Inactivation of the Human Vitamin D Receptor by Caspase-3 Endocrinology, February 1, 2009; 150(2): 679 - 686. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Genini and C. V. Catapano Block of Nuclear Receptor Ubiquitination: A MECHANISM OF LIGAND-DEPENDENT CONTROL OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR {delta} ACTIVITY J. Biol. Chem., April 20, 2007; 282(16): 11776 - 11785. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Man, H.-Y. Li, P.-J. Zhang, T. Zhou, K. He, X. Pan, B. Liang, A.-L. Li, J. Zhao, W.-L. Gong, et al. PIAS3 induction of PRB sumoylation represses PRB transactivation by destabilizing its retention in the nucleus Nucleic Acids Res., November 14, 2006; 34(19): 5552 - 5566. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Rosenfeld, V. V. Lunyak, and C. K. Glass Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response Genes & Dev., June 1, 2006; 20(11): 1405 - 1428. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Khadzkou, P. Buchwald, G. Westin, H. Dralle, G. Akerstrom, and P. Hellman 25-Hydroxyvitamin D3 1{alpha}-Hydroxylase and Vitamin D Receptor Expression in Papillary Thyroid Carcinoma J. Histochem. Cytochem., March 1, 2006; 54(3): 355 - 361. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Schneider, C. El-Yazidi, A. Dace, M. Maraninchi, R. Planells, A. Margotat, and J. Torresani Expression of the 1,25-(OH)2 vitamin D3 receptor gene during the differentiation of mouse Ob17 preadipocytes and cross talk with the thyroid hormone receptor signalling pathway J. Mol. Endocrinol., February 1, 2005; 34(1): 221 - 235. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fan, H. Nakshatri, and K. P. Nephew Inhibiting Proteasomal Proteolysis Sustains Estrogen Receptor-{alpha} Activation Mol. Endocrinol., November 1, 2004; 18(11): 2603 - 2615. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ismail, C. V. Nguyen, A. Ahene, J. C. Fleet, M. R. Uskokovic, and S. Peleg Effect of Cellular Environment on the Selective Activation of the Vitamin D Receptor by 1{alpha},25-Dihydroxyvitamin D3 and Its Analog 1{alpha}-Fluoro-16-Ene-20-Epi-23-Ene-26,27-Bishomo-25-Hydroxyvitamin D3 (Ro-26-9228) Mol. Endocrinol., April 1, 2004; 18(4): 874 - 887. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Moraitis and V. Giguere The Co-repressor Hairless Protects ROR{alpha} Orphan Nuclear Receptor from Proteasome-mediated Degradation J. Biol. Chem., December 26, 2003; 278(52): 52511 - 52518. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Woodham, L. Birch, and G. S. Prins Neonatal Estrogen Down-Regulates Prostatic Androgen Receptor through a Proteosome-Mediated Protein Degradation Pathway Endocrinology, November 1, 2003; 144(11): 4841 - 4850. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chauchereau, L. Amazit, M. Quesne, A. Guiochon-Mantel, and E. Milgrom Sumoylation of the Progesterone Receptor and of the Steroid Receptor Coactivator SRC-1 J. Biol. Chem., March 28, 2003; 278(14): 12335 - 12343. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wormke, M. Stoner, B. Saville, K. Walker, M. Abdelrahim, R. Burghardt, and S. Safe The Aryl Hydrocarbon Receptor Mediates Degradation of Estrogen Receptor {alpha} through Activation of Proteasomes Mol. Cell. Biol., March 15, 2003; 23(6): 1843 - 1855. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Qi, R. Pramanik, J. Wang, R. M. Schultz, R. K. Maitra, J. Han, H. F. DeLuca, and G. Chen The p38 and JNK Pathways Cooperate to trans-Activate Vitamin D Receptor via c-Jun/AP-1 and Sensitize Human Breast Cancer Cells to Vitamin D3-induced Growth Inhibition J. Biol. Chem., July 12, 2002; 277(29): 25884 - 25892. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Prufer, C. Schroder, K. Hegyi, and J. Barsony Degradation of RXRs Influences Sensitivity of Rat Osteosarcoma Cells to the Antiproliferative Effects of Calcitriol Mol. Endocrinol., May 1, 2002; 16(5): 961 - 976. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. He, N. T. Bowen, J. T. Minges, and E. M. Wilson Androgen-induced NH2- and COOH-terminal Interaction Inhibits p160 Coactivator Recruitment by Activation Function 2 J. Biol. Chem., November 2, 2001; 276(45): 42293 - 42301. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Poukka, U. Karvonen, O. A. Janne, and J. J. Palvimo Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1) PNAS, December 19, 2000; 97(26): 14145 - 14150. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Byrne, L. Flanagan, M. P. R. Tenniswood, and J. Welsh Identification of a Hormone-Responsive Promoter Immediately Upstream of Exon 1c in the Human Vitamin D Receptor Gene Endocrinology, August 1, 2000; 141(8): 2829 - 2836. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Boudjelal, Z. Wang, J. J. Voorhees, and G. J. Fisher Ubiquitin/Proteasome Pathway Regulates Levels of Retinoic Acid Receptor {{gamma}} and Retinoid X Receptor {{alpha}} in Human Keratinocytes Cancer Res., April 1, 2000; 60(8): 2247 - 2252. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |